Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	L-alanine:2-oxoglutarate aminotransferase activity	GPT GPT2	1.28e-05	2	72	2	GO:0004021
GeneOntologyMolecularFunction	alanine-oxo-acid transaminase activity	GPT GPT2	1.28e-05	2	72	2	GO:0047635
GeneOntologyCellularComponent	anchoring junction	ANK3 HMCN1 TIAM1 GIT1 DOCK7 PKP1 RPS19 PTPRU PARD3 AJUBA CNN2 TNS3	1.01e-04	976	71	12	GO:0070161
Domain	TIL	ZAN SSPOP	9.43e-04	12	72	2	PF01826
Domain	C8	ZAN SSPOP	9.43e-04	12	72	2	PF08742
Domain	Unchr_dom_Cys-rich	ZAN SSPOP	1.11e-03	13	72	2	IPR014853
Domain	C8	ZAN SSPOP	1.11e-03	13	72	2	SM00832
Domain	TIL_dom	ZAN SSPOP	1.29e-03	14	72	2	IPR002919
Domain	Ank_2	ANKRD33 ANK3 GIT1 USH1G SOWAHC	1.44e-03	215	72	5	PF12796
Domain	VWD	ZAN SSPOP	1.70e-03	16	72	2	SM00216
Domain	VWF_type-D	ZAN SSPOP	1.70e-03	16	72	2	IPR001846
Domain	MAM_1	ZAN PTPRU	1.70e-03	16	72	2	PS00740
Domain	VWFD	ZAN SSPOP	1.70e-03	16	72	2	PS51233
Domain	VWD	ZAN SSPOP	1.70e-03	16	72	2	PF00094
Domain	Ank	ANKRD33 ANK3 GIT1 USH1G SOWAHC	1.87e-03	228	72	5	PF00023
Domain	Aminotransferase_I/II	GPT GPT2	1.92e-03	17	72	2	IPR004839
Domain	Aminotran_1_2	GPT GPT2	1.92e-03	17	72	2	PF00155
Domain	MAM	ZAN PTPRU	1.92e-03	17	72	2	SM00137
Domain	MAM	ZAN PTPRU	2.15e-03	18	72	2	PF00629
Domain	MAM_dom	ZAN PTPRU	2.15e-03	18	72	2	IPR000998
Domain	MAM_2	ZAN PTPRU	2.15e-03	18	72	2	PS50060
Domain	VWC_out	ZAN SSPOP	2.40e-03	19	72	2	SM00215
Domain	-	ANKRD33 ANK3 GIT1 USH1G SOWAHC	2.69e-03	248	72	5	1.25.40.20
Domain	ANK	ANKRD33 ANK3 GIT1 USH1G SOWAHC	2.83e-03	251	72	5	SM00248
Domain	ANK_REPEAT	ANKRD33 ANK3 GIT1 USH1G SOWAHC	2.93e-03	253	72	5	PS50088
Domain	Ankyrin_rpt-contain_dom	ANKRD33 ANK3 GIT1 USH1G SOWAHC	2.98e-03	254	72	5	IPR020683
Domain	ANK_REP_REGION	ANKRD33 ANK3 GIT1 USH1G SOWAHC	2.98e-03	254	72	5	PS50297
Domain	Ankyrin_rpt	ANKRD33 ANK3 GIT1 USH1G SOWAHC	3.40e-03	262	72	5	IPR002110
Pubmed	Global Interactome Mapping of Mitochondrial Intermembrane Space Proteases Identifies a Novel Function for HTRA2.	UBR2 MPC2 ANK3 MRPS2 DOCK7 EXOC3 PARD3 SLC25A19 GPT2	1.19e-06	515	72	9	31617661
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	UBR2 TBC1D10B ANK3 TIAM1 LNPEP FBXL12 EXOC3 PTPRU AJUBA NCKAP5L TNS3 PPP6R3	1.55e-06	1049	72	12	27880917
Pubmed	Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma.	TCF4 AJUBA	4.23e-06	2	72	2	32802179
Pubmed	Par3 regulates invasion of pancreatic cancer cells via interaction with Tiam1.	TIAM1 PARD3	4.23e-06	2	72	2	26084985
Pubmed	Hepatic pyruvate and alanine metabolism are critical and complementary for maintenance of antioxidant capacity and resistance to oxidative insult.	MPC2 GPT2	4.23e-06	2	72	2	37716594
Pubmed	Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma.	GPT GPT2	4.23e-06	2	72	2	19360321
Pubmed	cDNA cloning, genomic structure, chromosomal mapping, and functional expression of a novel human alanine aminotransferase.	GPT GPT2	4.23e-06	2	72	2	11863375
Pubmed	Murine alanine aminotransferase: cDNA cloning, functional expression, and differential gene regulation in mouse fatty liver.	GPT GPT2	4.23e-06	2	72	2	15122758
Pubmed	Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and gluconeogenesis in mice.	MPC2 GPT2	4.23e-06	2	72	2	37942005
Pubmed	The Par-Tiam1 complex controls persistent migration by stabilizing microtubule-dependent front-rear polarity.	TIAM1 PARD3	4.23e-06	2	72	2	17825562
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	SH3BP2 DOCK7 RPRD2 PJA1 SPATS2 AJUBA SOWAHC NCKAP5L ASH2L TNS3 PPP6R3	9.09e-06	1038	72	11	26673895
Pubmed	Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration.	ANK3 TIAM1	1.27e-05	3	72	2	10893266
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MPC2 ANK3 TIAM1 GIT1 USH1G DOCK7 ZNRF1 EXOC3 RPS19 DDX20 PARD3 NCKAP5L	1.60e-05	1321	72	12	27173435
Pubmed	Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries.	TCF4 ANK3	2.53e-05	4	72	2	21037240
Pubmed	The PHCCEx domain of Tiam1/2 is a novel protein- and membrane-binding module.	TIAM1 PARD3	2.53e-05	4	72	2	19893486
Pubmed	Par-3 controls tight junction assembly through the Rac exchange factor Tiam1.	TIAM1 PARD3	2.53e-05	4	72	2	15723052
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	TRAF7 GIT1 FN3KRP EXOC3 RPS19 DDX20 NCKAP5L PPP6R3	2.95e-05	588	72	8	38580884
Pubmed	Mitochondrial Raf1 Regulates Glutamine Catabolism.	A2M MSRA ANK3 DHCR7 FN3KRP TNS3	3.02e-05	288	72	6	38496616
Pubmed	14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking.	TIAM1 GIT1 FN3KRP DOCK7 CNN2	4.34e-05	186	72	5	14744259
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	DOCK7 DDX20 PJA1 PARD3 ASH2L PPP6R3	4.80e-05	313	72	6	38270169
Pubmed	Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.	MSRA TCF4 ANK3	5.31e-05	35	72	3	22688191
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	A2M TBC1D10B GIT1 PKP1 DDX20 SPATS2 PARD3	5.81e-05	475	72	7	31040226
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	TBC1D10B TCF20 TIAM1 GIT1 PARP8 DOCK7 PARD3 NCKAP5L TNS3	7.07e-05	861	72	9	36931259
Pubmed	Identification of an FMNL2 Interactome by Quantitative Mass Spectrometry.	TBC1D10B FN3KRP DOCK7 PPP6R3	7.15e-05	106	72	4	38891874
Pubmed	Analysis of early C2C12 myogenesis identifies stably and differentially expressed transcriptional regulators whose knock-down inhibits myoblast differentiation.	CITED2 ANKRD33 DMRTA2	8.57e-05	41	72	3	22147266
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TRAF7 TBC1D10B SH3BP2 GPT CEP295 RSRC2 PARD3 SLC25A19 SOWAHC NCKAP5L	9.81e-05	1116	72	10	31753913
Pubmed	Genome-wide association study of hematological and biochemical traits in a Japanese population.	CITED2 GPLD1 DOCK7 KLHDC7B	1.01e-04	116	72	4	20139978
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	TBC1D10B ANK3 DHCR7 DOCK7 EXOC3 RPS19 PARD3 SLC25A19	1.08e-04	708	72	8	39231216
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	A2M TBC1D10B MRPS2 DHCR7 DOCK7 DDX20 SPATS2 RSRC2 PARD3 SLC25A19 CNN2	1.14e-04	1371	72	11	36244648
Pubmed	CCM1 regulates vascular-lumen organization by inducing endothelial polarity.	TIAM1 PARD3	1.17e-04	8	72	2	20332120
Pubmed	Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family.	TRAF7 UBR2 MRPS2 DHCR7 FN3KRP DOCK7 FBXL12 DDX20 SLC25A19	1.28e-04	931	72	9	27432908
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TCF20 DHCR7 RPRD2 CEP295 DDX20 RSRC2 NCKAP5L TNS3	1.37e-04	733	72	8	34672954
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TCF20 ANK3 DOCK7 RPRD2 PARD3 ASH2L PPP6R3	1.43e-04	549	72	7	38280479
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	TIAM1 GIT1 DOCK7 PARD3 PPP6R3	1.91e-04	255	72	5	15324660
Pubmed	A Glo1-Methylglyoxal Pathway that Is Perturbed in Maternal Diabetes Regulates Embryonic and Adult Neural Stem Cell Pools in Murine Offspring.	DOCK7 PARD3	2.30e-04	11	72	2	27760310
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	UBR2 MRPS2 DHCR7 RPS19 SPATS2 RSRC2 PARD3 GPT2 TNS3 PPP6R3	2.41e-04	1247	72	10	27684187
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	TBC1D10B MPC2 GIT1 PRICKLE2 SPATS2 PARD3	2.71e-04	430	72	6	32581705
Pubmed	Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.	GIT1 DOCK7 RPS19 CNN2 TNS3	3.19e-04	285	72	5	21423176
Pubmed	Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.	ASH2L PPP6R3	3.25e-04	13	72	2	17761849
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	PARP8 DOCK7 CEP295 PARD3 NCKAP5L PPP6R3	3.29e-04	446	72	6	24255178
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	ANK3 GPT DOCK7 GPT2 TNS3	4.28e-04	304	72	5	32235678
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	TCF20 PKP1 EXOC3 RPRD2 TNS3 PPP6R3	4.44e-04	472	72	6	38943005
Pubmed	Apical Restriction of the Planar Cell Polarity Component VANGL in Pancreatic Ducts Is Required to Maintain Epithelial Integrity.	PRICKLE2 PARD3	4.98e-04	16	72	2	32460029
Pubmed	Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease.	LNPEP SH3BP2	5.63e-04	17	72	2	22153077
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	UBR2 FN3KRP RPS19 ASH2L CNN2 PPP6R3	5.64e-04	494	72	6	26831064
Pubmed	Hirschsprung Disease Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	TCF4 DHCR7	6.33e-04	18	72	2	20301612
Pubmed	Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis.	TCF4 ANK3	6.33e-04	18	72	2	33323119
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	TBC1D10B GIT1 SH3BP2 PARP8 PTPRU SLC25A19 CNN2 IFNAR2	6.47e-04	925	72	8	28986522
Pubmed	Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system.	UBR2 FBXL12 ZNRF1	7.44e-04	85	72	3	19028597
Pubmed	Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly.	DOCK7 PARD3	7.84e-04	20	72	2	32294449
Pubmed	Molecular characterization of a novel transcription factor that controls stromelysin expression.	TCF4 TCF20	7.84e-04	20	72	2	7760812
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	MSRA GIT1 RPRD2 PARD3 EPHA8	8.94e-04	358	72	5	32460013
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	A2M LNPEP FN3KRP FBXL12 PTPRU NCKAP5L TNS3 PPP6R3	9.03e-04	974	72	8	28675297
Pubmed	Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.	TRAF7 MPC2 PARP8 FN3KRP PRICKLE2 ZNRF1 CA10	9.22e-04	750	72	7	11230166
Pubmed	RNA-Binding Protein IGF2BP2/IMP2 is a Critical Maternal Activator in Early Zygotic Genome Activation.	MPC2 RPS19	9.50e-04	22	72	2	31406667
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MSRA UBR2 ANK3 SH3BP2 RPRD2 SPATS2 PARD3 GPT2 SSPOP SLC25A37	9.60e-04	1489	72	10	28611215
Pubmed	Genome-wide association study identifies five new schizophrenia loci.	TCF4 ANK3	1.04e-03	23	72	2	21926974
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ANK3 DHCR7 DOCK7 RPS19 PJA1 PARD3 SLC25A19	1.13e-03	777	72	7	35844135
Pubmed	Par3 is essential for the establishment of planar cell polarity of inner ear hair cells.	TIAM1 PARD3	1.13e-03	24	72	2	30814219
Pubmed	p63 exerts spatio-temporal control of palatal epithelial cell fate to prevent cleft palate.	PKP1 AJUBA	1.13e-03	24	72	2	28604778
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	TBC1D10B LNPEP DOCK7 EXOC3 PARD3 TNS3	1.17e-03	569	72	6	30639242
Pubmed	Proximity interactions among centrosome components identify regulators of centriole duplication.	DOCK7 CEP295 PJA1	1.23e-03	101	72	3	24613305
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	TCF20 PRICKLE2 CEP295 TNS3	1.41e-03	233	72	4	37704626
Pubmed	Characterization of the zinc-induced Shank3 interactome of mouse synaptosome.	TCF20 ZAN GIT1	1.53e-03	109	72	3	29111324
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	TBC1D10B TCF20 MRPS2 DHCR7 DOCK7 RPS19 RSRC2 SLC25A19	1.76e-03	1082	72	8	38697112
Pubmed	Tcf4 Regulates Synaptic Plasticity, DNA Methylation, and Memory Function.	TCF4 GLRA2	1.77e-03	30	72	2	27568567
Pubmed	A network of heterochronic genes including Imp1 regulates temporal changes in stem cell properties.	TCF4 CA10	2.01e-03	32	72	2	24192035
Pubmed	Regulation of lung endoderm progenitor cell behavior by miR302/367.	TIAM1 PARD3	2.01e-03	32	72	2	21350014
Pubmed	Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer.	TCF4 TIAM1 DOCK7 ASH2L	2.02e-03	257	72	4	30945288
Pubmed	AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair.	TRAF7 GPT DDX20	2.06e-03	121	72	3	31900314
Interaction	RAC1 interactions	TRAF7 TBC1D10B ANK3 TIAM1 GIT1 LNPEP SH3BP2 DHCR7 DOCK7 EXOC3 PARD3 SOWAHC NCKAP5L TNS3	1.20e-05	1063	69	14	int:RAC1
Interaction	RHOF interactions	TBC1D10B ANK3 TIAM1 LNPEP DHCR7 DOCK7 EXOC3 PARD3 SOWAHC NCKAP5L TNS3	1.66e-05	673	69	11	int:RHOF
Interaction	RHOQ interactions	TRAF7 TBC1D10B TIAM1 GIT1 LNPEP DHCR7 EXOC3 PARD3 TNS3	1.91e-05	442	69	9	int:RHOQ
Interaction	ARRDC2 interactions	DDX20 PJA1 ASH2L PPP6R3	3.50e-05	54	69	4	int:ARRDC2
GeneFamily	Ankyrin repeat domain containing	ANKRD33 ANK3 GIT1 USH1G SOWAHC	3.25e-04	242	45	5	403
Coexpression	BENPORATH_NANOG_TARGETS	CITED2 TRAF7 TBC1D10B TCF20 TIAM1 DHCR7 PARP8 DDX20 RSRC2 IGFLR1 AJUBA CNN2	1.47e-05	988	72	12	M6616
Coexpression	GSE14350_IL2RB_KO_VS_WT_TEFF_UP	TIAM1 LNPEP PARP8 ZNRF1 IGFLR1 SOWAHC	1.88e-05	200	72	6	M3423
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GPLD1 ANK3 PRICKLE2 ZNRF1 PARD3	1.03e-05	178	72	5	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	A2M EBI3 MYO7B RPS19 IL4I1	1.06e-05	179	72	5	ba64bfb757d6e3be631ee95abfa24b47861f6a14
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CITED2 A2M HMCN1 SLC5A9 SPATS2	1.18e-05	183	72	5	6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e
ToppCell	facs-Liver-Hepatocytes-24m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPLD1 DHCR7 GPT PARD3 GPT2	1.18e-05	183	72	5	d0721c6aa426953a520d40e976b6e65aa7ca65e8
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M ZAN HMCN1 MYO7B SSPOP	1.21e-05	184	72	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M ZAN HMCN1 MYO7B SSPOP	1.21e-05	184	72	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M ZAN HMCN1 MYO7B SSPOP	1.21e-05	184	72	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	CF-Myeloid-cDC\|CF / Disease state, Lineage and Cell class	A2M MPC2 EBI3 SPATS2 IL4I1	1.25e-05	185	72	5	7f3d118845ff9f5f525796b0bbc6532a8ee323ab
ToppCell	3'-Distal_airway-Immune_Myeloid-Dendritic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZAN EBI3 RPS19 RAB20 IL4I1	1.35e-05	188	72	5	649d27b2ef735b481ec0ed4f7a9b39aacc472a78
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CPA6 TCF20 ANK3 PARP8 PRICKLE2	1.35e-05	188	72	5	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	Control-Myeloid-MoAM1\|Control / Disease group,lineage and cell class （2021.01.30）	TCF4 EBI3 RAB20 IL4I1 SSPOP	1.38e-05	189	72	5	55d5c2fb9e6ab556d42c83a1e985ee66e4cf9dba
ToppCell	BAL-Control-Myeloid-MoAM-MoAM1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TCF4 EBI3 RAB20 IL4I1 SSPOP	1.38e-05	189	72	5	ebb5e069fdca7cf8ffac16a57572e92d2593c86a
ToppCell	BAL-Control-Myeloid-MoAM-MoAM1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TCF4 EBI3 RAB20 IL4I1 SSPOP	1.38e-05	189	72	5	a59e4eaff430a443f9fa7edabe64e66a15b6bffb
ToppCell	BAL-Control-Myeloid-MoAM-MoAM1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCF4 EBI3 RAB20 IL4I1 SSPOP	1.42e-05	190	72	5	5c8aa310886c64ee5dce4ba46a3dd178da549529
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CITED2 A2M HMCN1 SLC5A9 SPATS2	1.42e-05	190	72	5	6f71a9f74af7cd9a674753cfc9833ebe5bba0fa2
ToppCell	BAL-Control-Myeloid-MoAM-MoAM1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCF4 EBI3 RAB20 IL4I1 SSPOP	1.42e-05	190	72	5	4b4fe93061c87605dddf5bec94fa07c749c722aa
ToppCell	3'_v3-Lung-Myeloid_Dendritic-DC2\|Lung / Manually curated celltypes from each tissue	TCF4 EBI3 IGFLR1 IL4I1 CNN2	1.42e-05	190	72	5	468525c05e38158a3b8a445882b2d63dfb1d2c63
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CITED2 A2M RPS19 RAB20 SLC25A19	1.45e-05	191	72	5	79e7089022063c5f2b2f1b27658c62b741f3a037
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	A2M HMCN1 PRICKLE2 HPSE2 PARD3	1.53e-05	193	72	5	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	CF-Myeloid-cDC\|Myeloid / Disease state, Lineage and Cell class	A2M MPC2 EBI3 SPATS2 IL4I1	1.57e-05	194	72	5	3feb8a0ba3368673c53e9cbd4980e73d18697718
ToppCell	IPF-Lymphoid-T\|Lymphoid / Disease state, Lineage and Cell class	CITED2 ANK3 TIAM1 PARP8 ZNRF1	1.65e-05	196	72	5	6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	A2M TCF4 ANK3 HMCN1 HPSE2	1.69e-05	197	72	5	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CITED2 A2M RPS19 SLC25A19 IL4I1	1.73e-05	198	72	5	963f028bf5491fa2b38982828a32ab96dcc34bf4
ToppCell	metastatic_Lymph_Node-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	CITED2 A2M SLC25A19 IL4I1 TNS3	1.81e-05	200	72	5	4758b96725699641b55a665533adf2d238032b09
ToppCell	metastatic_Lymph_Node-Myeloid_cells-mo-Mac\|metastatic_Lymph_Node / Location, Cell class and cell subclass	A2M RAB20 SLC25A19 IL4I1 TNS3	1.81e-05	200	72	5	91e80caa216879f25815f9b96f75234484f9913b
ToppCell	control-Plasmablast\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 RPS19 SPATS2 GPT2	5.88e-05	130	72	4	9fe3c5be8488d341cff38757daf7856c112410d0
ToppCell	facs-Marrow-B-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B PKP1 HPSE2 SSPOP	7.21e-05	137	72	4	4dcb15de821439011df1bb0bbd7682d674bd725d
ToppCell	facs-Marrow-B-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B PKP1 HPSE2 SSPOP	7.21e-05	137	72	4	c05ceeb7b483324604cb3f647d2da2b3786071b1
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CITED2 TCF4 TIAM1 TNS3	9.22e-05	146	72	4	47368f981180ca6a8c81a50f7f9430f12456f609
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	A2M ZBTB5 EXOC3 IL4I1	9.47e-05	147	72	4	48d72b6770cd029dd299676e5d83e6ac62102049
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TCF4 TIAM1 GLRA2 TNS3	1.16e-04	155	72	4	99e749f7075e2c64e9a0bf91009f95b6969197c8
ToppCell	Mild-MAIT\|Mild / Disease group and Cell class	A2M ZNRF1 CA10 IL4I1	1.34e-04	161	72	4	0c1a04485708d5302600cdc2d7dac1cb76b4033a
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EBI3 GIT1 GUCY2D IL4I1	1.48e-04	165	72	4	60b500eb2c10cccf309b8fb28a9119da22d6889c
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	CPA6 TIAM1 EBI3 IL4I1	1.51e-04	166	72	4	773673a5d0430640439845b264740bfbbdad0cb2
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like\|GI_small-bowel / Manually curated celltypes from each tissue	CPA6 TIAM1 EBI3 IL4I1	1.55e-04	167	72	4	3ae46c6363da76c8e1f5579e6027bf88ed637a44
ToppCell	facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M HMCN1 PTPRU PARD3	1.58e-04	168	72	4	06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	TCF4 ZNRF1 AJUBA IL4I1	1.58e-04	168	72	4	d8f485f8459532a2cb0bef899e6569142cf75685
ToppCell	facs-Heart-RA-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M HMCN1 PTPRU PARD3	1.58e-04	168	72	4	1002f058a340763e3d8de0bd1f0547a903526ec6
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GPLD1 ANK3 PRICKLE2 PARD3	1.66e-04	170	72	4	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	NS-critical-d_0-4-Myeloid-Monocyte-derived_Macrophage\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MYO7B MRPS2 KLHDC7B DDX20	1.66e-04	170	72	4	adf73bdc049d508f8873c22539db2ca92052a97b
ToppCell	10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	TCF4 TIAM1 IL4I1 TNS3	1.66e-04	170	72	4	97df5ffb328196c46568975d2d97722bcc753bf5
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CITED2 TCF4 TIAM1 GLRA2	1.69e-04	171	72	4	5efd15300f865ebf651e0888265cbd717bc3b9d3
ToppCell	Mesenchymal_cells-Osteo-CAR\|Mesenchymal_cells / Lineage and Cell class	A2M CNN2 TNS3 IFNAR2	1.81e-04	174	72	4	430e3cd61bc2a471959faa40e817aa4dd7d82d28
ToppCell	wk_15-18-Hematologic-Myeloid-aDC_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	EBI3 IGFLR1 SLC25A19 IL4I1	1.85e-04	175	72	4	c31178d7a5a19d7afd336c9ec0e5c493655a6aa4
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HMCN1 SLC5A9 IGFLR1 IL4I1	1.85e-04	175	72	4	c58a1f02d1e559d3638fe1500e960e82a8a7187b
ToppCell	3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CPA6 DMRTA2 AJUBA CA10	1.93e-04	177	72	4	9e65b39fd797b6ce204b6480415810d1923acee5
ToppCell	ASK428-Epithelial-Secretory\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	TBC1D10B KLHDC7B NCKAP5L HARBI1	1.93e-04	177	72	4	66074a288501c136b4e83b883db5f0d8269ee326
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	A2M MYO7B RPS19 IL4I1	1.93e-04	177	72	4	3a94ee9b58ebdbbc75e00954cf1f6922f88f8f88
ToppCell	10x5'v1-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M EBI3 USH1G IL4I1	1.93e-04	177	72	4	945b2d0723a0a35c767604ae607d2c2d53bf0c82
ToppCell	Dendritic_Cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	A2M EBI3 IGFLR1 IL4I1	1.98e-04	178	72	4	3a28103cf282cc3637d1875a3b4cd7ddf3207687
ToppCell	10x3'2.3-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	A2M ANKRD33 EBI3 IL4I1	1.98e-04	178	72	4	e44b0aa82890ae84fc4d1343f1c65ae2fda69a11
ToppCell	BAL-Control-Myeloid-MoAM-MoAM2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CPA6 EBI3 IL4I1 SLC25A37	2.02e-04	179	72	4	898425fa81526a2e00fca7a25085229ff1f31069
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	A2M EBI3 RPS19 IL4I1	2.02e-04	179	72	4	8bd85ee92791996377bcafed198c1bb3c9af4c3c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MSRA MYO7B SH3BP2 GPT	2.02e-04	179	72	4	d1ef7e1cb00336118e387b47f4f8120f53584391
ToppCell	BAL-Control-Myeloid-MoAM-MoAM2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CPA6 EBI3 IL4I1 SLC25A37	2.02e-04	179	72	4	2fca4117c58824562ec80c7713fe15689a28efb3
ToppCell	BAL-Control-Myeloid-MoAM-MoAM2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CPA6 EBI3 IL4I1 SLC25A37	2.06e-04	180	72	4	f3d8329b7e754c1ed89b0f39b8cd9e2ae22f6725
ToppCell	P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANK3 RAB20 GPT2 CA10	2.06e-04	180	72	4	1e819c5c87704ec6535dfeaae56561895e239d07
ToppCell	BAL-Control-Myeloid-MoAM-MoAM2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CPA6 EBI3 IL4I1 SLC25A37	2.06e-04	180	72	4	dcec59d66995f701d816eaeea3ed1439a2f71b73
ToppCell	Control-Myeloid-MoAM2\|Control / Disease group,lineage and cell class （2021.01.30）	CPA6 EBI3 IL4I1 SLC25A37	2.06e-04	180	72	4	38892483a6a5388765aec87f0119c0b9bb5c7cbd
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	TCF20 TIAM1 EBI3 IGFLR1	2.11e-04	181	72	4	b193f3606554adc55c5906219d114288bb1f978a
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs\|Myeloid_cells / Location, Cell class and cell subclass	GPLD1 MPC2 RPS19 SPATS2	2.11e-04	181	72	4	cc7ae1221a28bc404138a7efee0ad08a19cc3d86
ToppCell	Control-Epithelial-Basal\|World / Disease state, Lineage and Cell class	ANK3 PKP1 PTPRU PARD3	2.15e-04	182	72	4	759390dde9b18757f7675d13d44c89d0e32f8d93
ToppCell	droplet-Liver-Npc-21m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TIAM1 USH1G PTPRU TNS3	2.15e-04	182	72	4	dc55de945c6f78f32eb3a1b3520835eb8417e068
ToppCell	CTRL-Myeloid-cDC\|Myeloid / Disease state, Lineage and Cell class	TCF4 EBI3 ZNRF1 IL4I1	2.15e-04	182	72	4	ee137574b8f0e684a4a7cb26226877c471cae433
ToppCell	Control-Epithelial-Basal\|Control / Disease state, Lineage and Cell class	ANK3 PKP1 PTPRU PARD3	2.15e-04	182	72	4	caddd0a52f0234ea6a916186ffaf2454cdcd80ee
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TIAM1 USH1G PTPRU TNS3	2.15e-04	182	72	4	010a7364da46101cb5068891fd7bc712ea8f13bd
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TIAM1 USH1G PTPRU TNS3	2.15e-04	182	72	4	b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MSRA MYO7B SLC5A9 GPT2	2.20e-04	183	72	4	84b64cf728629c3af9a8d2ed15b93adf562c54b8
ToppCell	facs-Skin-Telogen-3m-Epithelial-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPT PKP1 SOWAHC CNN2	2.20e-04	183	72	4	26b18d1cc5d98f185176e100bafb9bc9081c66f7
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M PRICKLE2 HPSE2 ACSM6	2.20e-04	183	72	4	5377b4fbd8fdfe68933b4c0965aa9525f7f31591
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CITED2 A2M HMCN1 AJUBA	2.20e-04	183	72	4	b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EBI3 SH3BP2 IL4I1 SLC25A37	2.24e-04	184	72	4	857ca1fc4de07b300839b22924211dc624453841
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	ANK3 DHCR7 CEP295 PJA1	2.29e-04	185	72	4	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SH3BP2 HPSE2 PARD3 TNS3	2.34e-04	186	72	4	73cf266aeecd3cc15e8cb6094588a393bca8fbe6
ToppCell	COVID-19_Convalescent-PLT_4\|World / Disease Group and Platelet Clusters	CITED2 TCF4 CEP295 RSRC2	2.34e-04	186	72	4	5954a1e3ffafb33f2a9bc87af3343f304fda4c92
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	CPA6 TCF20 PRICKLE2 SPATS2	2.34e-04	186	72	4	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	CPA6 TCF20 PRICKLE2 SPATS2	2.34e-04	186	72	4	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CITED2 A2M PARP8 IL4I1	2.38e-04	187	72	4	f1ba41f2ec703251a81c46e08d45e70210f298e7
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CITED2 A2M ANK3 IL4I1	2.38e-04	187	72	4	e1d6c1194476cf26969e405b0951796fed519f44
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	A2M TCF4 HMCN1 HPSE2	2.38e-04	187	72	4	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	tumor_Lung-B_lymphocytes-GC_B_cells_in_the_LZ\|B_lymphocytes / Location, Cell class and cell subclass	EBI3 SPATS2 IL4I1 CNN2	2.53e-04	190	72	4	bfb16efb23add53eebabc8e48f20c96994ec01da
ToppCell	IPF-Epithelial-Basal\|IPF / Disease state, Lineage and Cell class	ANK3 PKP1 PTPRU PARD3	2.53e-04	190	72	4	ea19e9ce954f2dfde97388db9695325cd92ab88f
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SH3BP2 HPSE2 PARD3 TNS3	2.53e-04	190	72	4	3a55cc5dc2549788bfe55f649686887b21a1fdd2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CITED2 A2M RPS19 SLC25A19	2.53e-04	190	72	4	e950f40d578c1eec8c6030cf1cb51823eac24bc7
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SH3BP2 HPSE2 PARD3 TNS3	2.53e-04	190	72	4	b56c55f608b30f7379941ac7d5f0f5200f305fca
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SH3BP2 HPSE2 PARD3 TNS3	2.53e-04	190	72	4	1c3d601422efa60fad8565f9ccd9032b847e4a91
ToppCell	Control-Myeloid-cDC2\|World / Disease state, Lineage and Cell class	TCF4 EBI3 IGFLR1 IL4I1	2.58e-04	191	72	4	11dfd8f38beb294f42710cfbd355cb089e1023c0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MSRA ANK3 MYO7B PARD3	2.58e-04	191	72	4	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M CPA6 PRICKLE2 HPSE2	2.58e-04	191	72	4	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MSRA ANK3 MYO7B PARD3	2.58e-04	191	72	4	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M CPA6 PRICKLE2 HPSE2	2.58e-04	191	72	4	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M CPA6 PRICKLE2 HPSE2	2.58e-04	191	72	4	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SH3BP2 HPSE2 PARD3 TNS3	2.64e-04	192	72	4	f7e4509003d71f805b9d4587098e90d2897b6739
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	EBI3 IGFLR1 SLC25A19 EPHA8	2.64e-04	192	72	4	5ea1a8119012eb8bc3100b739a0430377a8ac534
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SH3BP2 HPSE2 PARD3 TNS3	2.64e-04	192	72	4	43beaac1de99b9c1a6dab4a450b4e81286987b64
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	A2M DHCR7 PARP8 IL4I1	2.64e-04	192	72	4	892789bdba150ef9a8a0012de52545f2ff6a31f6
ToppCell	COVID-19_Mild-Lymphoid_T/NK-MAIT\|COVID-19_Mild / Disease group, lineage and cell class	A2M DHCR7 PARP8 IL4I1	2.64e-04	192	72	4	d47bd132e57f5b4bddcf3dfa399cee149eca7e44
ToppCell	IPF-Epithelial-Basal\|World / Disease state, Lineage and Cell class	ANK3 PKP1 PTPRU PARD3	2.64e-04	192	72	4	9b91e0b162e6f3ce86dd15cc33c2e745d069581f
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	A2M DHCR7 PARP8 IL4I1	2.64e-04	192	72	4	24ea8fdcca2695aeb2e4b88161184124b7d332c1
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	A2M DHCR7 PARP8 IL4I1	2.64e-04	192	72	4	44f440ee3842fe14665c4cd4f2aa48e7a5bbd9a8
Drug	4-tert-butylthiazole	GPT GPT2	9.86e-06	2	72	2	CID000581111
Drug	cetefloxacin	GPT GPT2	9.86e-06	2	72	2	CID000065995
Drug	1-fluorohexane	GPT GPT2	9.86e-06	2	72	2	CID000009760
Drug	Apiopeonoside	GPT GPT2	9.86e-06	2	72	2	CID000127509
Drug	L-645,164	GPT GPT2	9.86e-06	2	72	2	CID006439709
Drug	4-chlorobenzothioamide	GPT GPT2	9.86e-06	2	72	2	CID002734826
Drug	paeonoside	GPT GPT2	9.86e-06	2	72	2	CID000442924
Drug	p-methoxythiobenzamide	GPT GPT2	9.86e-06	2	72	2	CID000736827
Drug	S00305	GPT GPT2	9.86e-06	2	72	2	CID006419754
Drug	2-phenylthiazole	GPT GPT2	9.86e-06	2	72	2	CID000547494
Drug	deoxoviroidin	GPT GPT2	9.86e-06	2	72	2	CID000156810
Drug	deoxoviroisin	GPT GPT2	9.86e-06	2	72	2	CID000156812
Drug	bu-MDI	GPT GPT2	2.95e-05	3	72	2	CID000428359
Drug	AC1L9K40	GPT GPT2	2.95e-05	3	72	2	CID000446804
Drug	Schisantherin E	GPT GPT2	2.95e-05	3	72	2	CID005321177
Drug	1-fluoropentane	GPT GPT2	2.95e-05	3	72	2	CID000011603
Drug	Calycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TIAM1 GIT1 PTPRU IGFLR1 PARD3 IFNAR2	4.00e-05	199	72	6	6221_DN
Drug	3-(cystein-S-yl)acetaminophen	GPT GPT2	5.89e-05	4	72	2	CID000171264
Drug	AC1NUKHP	GPT GPT2	5.89e-05	4	72	2	CID005481353
Drug	2,6-dimethyl-1-nitrosopiperidine	GPT GPT2	5.89e-05	4	72	2	CID000028717
Drug	1-amino-1,2-dimethyl-guanidine	GPT GPT2	5.89e-05	4	72	2	CID010034592
Drug	1-amino-1-methyl-guanidine	GPT GPT2	5.89e-05	4	72	2	CID003848779
Drug	U 52267	GPT GPT2	5.89e-05	4	72	2	CID000169520
Drug	AC1O43SP	GPT GPT2	5.89e-05	4	72	2	CID006323533
Drug	AC1L1H6Q	GPT GPT2	5.89e-05	4	72	2	CID000004000
Drug	1-amino-3-methylguanidine	GPT GPT2	5.89e-05	4	72	2	CID000415736
Drug	acetylkynurenine	GPT GPT2	5.89e-05	4	72	2	CID005231549
Drug	dec-2-ynal	GPT GPT2	5.89e-05	4	72	2	CID011252117
Drug	NSC-88947	GPT GPT2	9.80e-05	5	72	2	CID005351908
Drug	RG 12915	GPT GPT2	9.80e-05	5	72	2	CID000130427
Drug	FK-3	GPT GPT2	9.80e-05	5	72	2	CID000127417
Drug	2-naphthylisothiocyanate	GPT GPT2	9.80e-05	5	72	2	CID000074222
Drug	chloro-1,1,1-trifluoroethane	GPT GPT2	1.47e-04	6	72	2	CID000006408
Drug	galbacin	GPT GPT2	1.47e-04	6	72	2	CID000234441
Drug	TFLA	GPT GPT2	1.47e-04	6	72	2	CID005488006
Drug	2-hcehc	GPT GPT2	1.47e-04	6	72	2	CID000152815
Drug	N-ethylphenylacetamide	GPT GPT2	1.47e-04	6	72	2	CID000079591
Drug	estragole oxide	GPT GPT2	1.47e-04	6	72	2	CID000040004
Drug	glycrrhizin	GLRA2 GPT GPT2 IL4I1	1.60e-04	86	72	4	CID000003495
Drug	gemcadiol	GPT GPT2	2.05e-04	7	72	2	CID000037147
Drug	picroside II	GPT GPT2	2.05e-04	7	72	2	CID003081484
Drug	Ternatin Heptapeptide	GPT GPT2	2.05e-04	7	72	2	CID000192406
Drug	Phenelzine	GPT GPT2	2.05e-04	7	72	2	DB00780
Drug	Hoe 704	GPT GPT2	2.05e-04	7	72	2	CID000119559
Drug	2-oxoglutaconic acid	GPT GPT2	2.05e-04	7	72	2	CID006443759
Disease	liver cancer (is_marker_for)	GPT GPT2	2.09e-04	9	72	2	DOID:3571 (is_marker_for)
Disease	membranous glomerulonephritis (biomarker_via_orthology)	A2M PTPRU	5.24e-04	14	72	2	DOID:10976 (biomarker_via_orthology)
Disease	pain	TCF4 HPSE2 RPRD2 CA10	1.37e-03	196	72	4	EFO_0003843
Disease	non-alcoholic fatty liver disease (is_marker_for)	GPT GPT2	1.98e-03	27	72	2	DOID:0080208 (is_marker_for)
Disease	corneal endothelial cell measurement	MSRA TCF4 PJA1	2.37e-03	108	72	3	EFO_0010079

Protein segments in the cluster

Peptide	Gene	Start	Entry
GLGTMVFRRNYLSSG	USH1G	311	Q495M9
GSGFGQREGTYHFRM	GPT2	481	Q8TD30
GFGQREGTYHFRMTI	GPT	456	P24298
ASARGHMLYLTGDRG	ACSM6	441	Q6P461
HSFRSGMDASNGYRA	ARSD	101	P51689
RTSGISMGYDQRHGS	AJUBA	161	Q96IF1
GAFSLSGYNRVMRAA	SH3BP2	71	P78314
GGSTHRRDRQAFSMY	GIT1	496	Q9Y2X7
ETYMHRIGRAGRFGT	DDX20	391	Q9UHI6
GVARHFNYVGDLMGS	DHCR7	401	Q9UBM7
HMFSIGRSYEGRSLF	CPA6	161	Q8N4T0
HSRGLAFMAPYSTAG	DMRTA2	476	Q96SC8
GFYESDVMGRGHARL	A2M	706	P01023
GYSMVRASHGVRKGA	ASH2L	406	Q9UBL3
QFHGLGSMYCRGAAA	RAB20	61	Q9NX57
GRTGLMVACYHGFQS	ANKRD33	131	Q7Z3H0
GMRQGNDHGTQYRSA	MSRA	146	Q9UJ68
MSAAGARGLRATYHR	MPC2	1	O95563
SNTRLQLHGAMYGSG	PARP8	716	Q8N3A8
DPGARVYSSHSMGAR	NCKAP5L	746	Q9HCH0
SFLSAGTRMHFPRGG	GUCY2D	426	Q02846
HFGSGYRGSSLNIMR	FN3KRP	291	Q9HA64
LARRRSGGGTVYHDM	LIPT1	96	Q9Y234
GYGTGLLSANRHSLM	TCF4	436	P15884
ALGFYTSGSFQTRMG	HARBI1	76	Q96MB7
FMNRSSGLRNSATGY	LNPEP	81	Q9UIQ6
YRTMHGRAVNGSQLG	HPSE2	266	Q8WWQ2
FIVGSHRYRMTSDGT	HMCN1	651	Q96RW7
RTSGGGYTMHGLTVR	IFNAR2	331	P48551
RLGLSFMDTHGYSTR	PTPRU	821	Q92729
SFQESMGHGSRRDLY	PRICKLE2	731	Q7Z3G6
GGSVHYATMARSAVR	DOCK7	871	Q96N67
SIRMGRYRDHFAAGG	EPHA8	941	P29322
GMAHGTTRHLAARYG	IGFLR1	276	Q9H665
SFIATYRLGMAARGH	EBI3	61	Q14213
GYMGFSLGARSASLR	ANK3	901	Q12955
RESRFNFSGYGMGHC	GLRA2	366	P23416
TMHNYLFLAGGIRGS	KLHDC7B	351	Q96G42
NTRDMTLIHGYFGST	EXOC3	166	O60645
GRKVSGTMYNTGRHV	CA10	91	Q9NS85
GTMYNTGRHVSLRLD	CA10	96	Q9NS85
YLASLRSMGEGHRQA	CEP295	86	Q9C0D2
ETLGYHSASNRRMSG	RPRD2	1086	Q5VT52
RNGYLGGHGFNARVM	PARD3	1266	Q8TEW0
GGHSNTDRPSRMIFY	IL4I1	371	Q96RQ9
TLSHSNRGSMYDGLA	PKP1	61	Q13835
RSQTHTQRGMGLGFT	RSRC2	411	Q7L4I2
ARHLYLRGGAGVGSM	RPS19	61	P39019
HGQLYASGAMARLDS	SSPOP	2951	A2VEC9
SRSYHFGIVGLNMNG	POMGNT1	496	Q8WZA1
LHSLRMGGYLFSGSQ	FBXL12	71	Q9NXK8
SGRLSGMANAFRTVY	SLC25A37	276	Q9NYZ2
RGTIGGYFLAGRSMS	SLC5A9	61	Q2M3M2
ARTSGGYTALHLAAM	SOWAHC	336	Q53LP3
VRDSHSFRGAYGLAM	TNS3	1196	Q68CZ2
AHTRYFRGGMLTNAR	MRPS2	166	Q9Y399
IHYGAGNMNATSGIR	CITED2	56	Q99967
ASQSGMTAYGTRRHL	CNN2	176	Q99439
NQGRHDSMGRYRNSS	SPATS2	466	Q86XZ4
QFGMDFSRSGLGLHS	ZBTB5	501	O15062
GRRQHSYTSNGPTFM	TIAM1	146	Q13009
LHQGGATRMYALTSD	GPLD1	686	P80108
MSSGKSARYNRFSGG	TRAF7	1	Q6Q0C0
MFAARGGHGQQDLYR	TBC1D10B	416	Q4KMP7
RRYSRSTQEHQGMAG	TCF20	766	Q9UGU0
HRYRMTTSGGGGFCD	UBR2	136	Q8IWV8
ASGSRRGMAYGHIDS	PJA1	106	Q8NG27
GGRRHGYMGHLTRIA	PPP6R3	451	Q5H9R7
NTLRHAVGTMYRSEG	SLC25A19	156	Q9HC21
MSGSHGFQGGRYRLG	ZNF214	156	Q9UL59
HYRTGGGAMGLRSRS	ZNRF1	36	Q8ND25
GSYLHMESNSFHRGG	ZAN	86	Q9Y493
STYFHMALGSLGRGS	MYO7B	2061	Q6PIF6